FMS Atlantic City Holdings, LLC
FMS Atlantic City Holdings, LLC was paid $5.10M by Medicaid between Aug 2018 and Oct 2024, across 40 billing codes. Its largest line is 90935, Hemodialysis procedure with single evaluation by a physician — 72% of everything it billed.
ATLANTIC CITY, NJ 08401
Next to other End-Stage Renal Disease (ESRD) Treatment Clinic/Center providers in New Jersey
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,512 | $155K | |
| 2019 | 9,978 | $668K | |
| 2020 | 26,808 | $622K | |
| 2021 | 41,446 | $983K | |
| 2022 | 51,272 | $961K | |
| 2023 | 53,426 | $886K | |
| 2024incomplete | 65,751 | $823K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 72% | 25,161 | 1,885 | $3.69M |
| 90999 | Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient | 20% | 24,569 | 1,685 | $1.02M |
| A4657 | Syringe, with or without needle, each | 2.7% | 46,698 | 2,619 | $139K |
| 85018 | <1% | 9,058 | 2,176 | $41K | |
| 84520 | <1% | 4,938 | 2,085 | $26K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 9,622 | 1,607 | $22K |
| 83540 | <1% | 3,321 | 2,224 | $17K | |
| 83970 | <1% | 3,287 | 2,249 | $17K | |
| 84155 | <1% | 3,035 | 2,063 | $14K | |
| 84460 | <1% | 3,224 | 2,238 | $13K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,109 | 2,113 | $13K |
| 82310 | <1% | 1,959 | 1,176 | $13K |
28 more codes
| 84100 | <1% | 1,798 | $9K | |
| 82728 | <1% | 2,138 | $9K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | <1% | 3,909 | $6K |
| 83735 | <1% | 998 | $6K | |
| 82040 | <1% | 1,515 | $5K | |
| 84075 | <1% | 1,527 | $5K | |
| 82108 | <1% | 538 | $4K | |
| 82565 | <1% | 1,364 | $4K | |
| 84466 | <1% | 62 | $4K | |
| 80051 | <1% | 1,377 | $3K | |
| 86706 | <1% | 296 | $3K | |
| 87340 | <1% | 687 | $3K | |
| 80069 | <1% | 1,316 | $2K | |
| 82746 | <1% | 172 | $1K | |
| OP250 | <1% | 37,169 | $521.89 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | <1% | 207 | $433.74 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 49,449 | $49.47 |
| 90686 | <1% | 82 | $35.55 | |
| 83550 | <1% | 2,794 | $31.04 | |
| G0008 | Administration of influenza virus vaccine | <1% | 196 | $2.94 |
| 90682 | 0% | 46 | $0.00 | |
| 84450 | 0% | 575 | $0.00 | |
| A6216 | Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 0% | 1,388 | $0.00 |
| 0002A | 0% | 13 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 194 | $0.00 |
| J3490 | Unclassified drugs | 0% | 3,135 | $0.00 |
| 86803 | 0% | 250 | $0.00 | |
| 84132 | 0% | 1,017 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.